# A Study to Investigate the Drug-drug Interactions Between ACT-541468 and Ethanol in Healthy Subjects

> **NCT03609775** · PHASE1 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ACT-541468
- **OTHER:** ACT-541468 placebo
- **OTHER:** Ethanol 10%
- **OTHER:** Ethanol placebo

## Key facts

- **NCT ID:** NCT03609775
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-28
- **Primary completion:** 2018-10-09
- **Final completion:** 2018-10-09
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03609775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03609775, "A Study to Investigate the Drug-drug Interactions Between ACT-541468 and Ethanol in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03609775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*